0RAF.L - Amplitude Surgical SA
| Previous close | 0.0000 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.097M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2490 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireAmplitude Surgical: Consolidated 9-Month Sales of €75.4 Million, up 15.8% at Constant Exchange Rates
VALENCE, France, April 20, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the third quarter and first 9 months of its 2022-23 financial year.
Business WireAmplitude Surgical announces the signing of a definitive agreement for the sale of Novastep's activities
VALENCE, France, April 03, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces the signing of a definitive agreement with Enovis Corporation for the sale of its whole Novastep business, specialized in clinically proven foot and ankle solutions.
Business WireAmplitude Surgical Announces Its Results for the First Half of 2022-23: Sales of €45.2 Million and EBITDA of €11.7 Million
VALENCE, France, March 22, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its results for the first half of its 2022-23 financial year.
Business WireAmplitude Surgical – H1 2022-23: Consolidated Sales of €45.2 Million, +10.8% at Constant Exchange Rates
VALENCE, France, February 23, 2023--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first half of its 2022-23 financial year.
Business WireAmplitude Surgical – First Quarter 2022-23: Consolidated Sales of €19.4 Million, +11.3% at Constant Exchange Rates
VALENCE, France, November 24, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first quarter of its 2022-23 financial year.
Business WireAmplitude Surgical Announces Its 2022-23 Financial Calendar
VALENCE, France, November 24, 2022--Regulatory News: Amplitude Surgical (ISIN : FR0012789667, Mnémo : AMPLI, PEA-PME eligible) (Paris:AMPLI), ("Amplitude" or the "Group"), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2022-23 financial calendar.
Business WireAmplitude Surgical – 2021-22 Annual Results: Sales of €87.6m and EBITDA of €22.0m
VALENCE, France, October 19, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its 2021-22 annual results.
Business WireAmplitude Surgical – Consolidated Annual Sales of €104.8 Million, up 8.2% at Constant Exchange Rates
VALENCE, France, July 21, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans) (Paris:AMPLI), a leading French player on the surgical technologies market for lower-limb orthopedics, announces its consolidated sales for its 2021-22 financial year.
StockopediaWhich way to trade Amplitude Surgical SA (EPA:AMPLI)?
As any reader of this is probably aware, shares in Amplitude Surgical SA (EPA:AMPLI) are currently trading close to a 52 week high, with the share price up by...
Business WireAmplitude Surgical – Launch of a Strategic Review of Novastep’s Foot and Ankle Activities
VALENCE, France, June 28, 2022--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans), leading French player on the surgical technology market for lower-limb orthopedics, announces the launch of a strategic review of its Novastep activity specializing in foot and ankle surgery.